Whereas two studies have shown an association of survivin staining with an increased risk of local progression14,19, another study by Kaur et al. could not detect any association between survivin and prognostic or clinco-pathological parameters including pT stage, grading, or cancer relapse after radical prostatectomy16. The gene discussed is BIRC5; the disease is cancer.